al effects of progestins and estrogens on long control regions of human papillomavirus types 16 and 18. Biochem Biophys Res Commun 1996; 224:651-659. 10. Arbeit JM, Howley PM, Hanahan D. Chronic estrogen-induced cervical and vaginal squamous carcinogenesis in human papillomavirus type 16 transgenic mice. Proc Natl Acad Sci USA 1996; 93:2930-2935. 11. Michelin D, Gissmann L, Street D, et al. Regulation of human papillomavirus type 18 in vivo: Effects of estrogen and progesterone in transgenic mice. Gynecol Oncol 1997; 66:202-208. 12. Schon H, Grgurin M, Szekeres T, et al. A new mode of treatment of human papilloma virus associated anogenital lesions using a nonsteroid estrogen analogue.Wien Klin Wochenschr 1996; 108:45-47. 13. Brinton LA, Schairer C, Haenszel W, et al. Cigarette smoking and invasive cervical cancer. JAMA 1986;255:3265-3269. 14. Clarke EA, Morgan RW, Newman AM. Smoking as a risk factor in cancer of the cervix: Additional evidence from a case-control study. Am J Epidemiol 1982;115:59-66. 15. La Vecchia C, Franceschi S, Decarli A, et al. Cigarette smoking and the risk of cervical neoplasia. Am J Epidemiol 1986; 123:22. 16. Slattery ML, Robinson LM, Schuman KL, et al. Cigarette smoking and exposure to passive smoke are risk factors for cervical cancer. JAMA 1989;261:1593. 17. Burger MM, Hollema H. Gouw AH, et al. Cigarette smoking and human papillomavirus in patients with reported cervical cytological abnormality. Br Med J 1993;306:749. 18. Schiffman MH, Haley NJ, Felton JS, et al. Biochemical epidemiology of cervical neoplasia: measuring cigarette smoke constituents in the cervix. Cancer Res 1987;47:3886. 19. Prokopczyk B, Cox JE, Hoffman D, et al. Identification of tobacco-specific carcinogens in the cervical mucus of smokers and nonsmokers. J Natl Cancer Inst 1997;89:868-873. ...
